BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang N, Ma J, Wang KS, Mi C, Lv Y, Piao LX, Xu GH, Li X, Lee JJ, Jin X. Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression. Mol Cell Biochem 2016;422:11-20. [PMID: 27686451 DOI: 10.1007/s11010-016-2799-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu J, Zhang Z, Zhang L, Jin X, Ma J, Piao H. Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1α pathway. Bioorganic & Medicinal Chemistry Letters 2019;29:853-8. [DOI: 10.1016/j.bmcl.2018.12.060] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chu J, Wang X, Bi H, Li L, Ren M, Wang J. Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model. Int Immunopharmacol 2018;59:174-80. [PMID: 29656207 DOI: 10.1016/j.intimp.2018.04.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
3 Liu D, Mao Y, Ding L, Zeng XA. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability. Trends Food Sci Technol 2019;91:586-97. [PMID: 32288229 DOI: 10.1016/j.tifs.2019.07.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
4 Martínez-Coria H, Mendoza-Rojas MX, Arrieta-Cruz I, López-Valdés HE. Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases. Front Pharmacol 2019;10:1334. [PMID: 31780947 DOI: 10.3389/fphar.2019.01334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Zeng Y, Peng Y, Tang K, Wang YQ, Zhao ZY, Wei XY, Xu XL. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages. Biomed Pharmacother 2018;101:543-52. [PMID: 29505925 DOI: 10.1016/j.biopha.2018.02.124] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
6 Wu Y, Xiao Y, Yue Y, Zhong K, Zhao Y, Gao H. A deep insight into mechanism for inclusion of 2R,3R-dihydromyricetin with cyclodextrins and the effect of complexation on antioxidant and lipid-lowering activities. Food Hydrocolloids 2020;103:105718. [DOI: 10.1016/j.foodhyd.2020.105718] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
7 Moon NR, Kang S, Park S. Consumption of ellagic acid and dihydromyricetin synergistically protects against UV-B induced photoaging, possibly by activating both TGF-β1 and wnt signaling pathways. J Photochem Photobiol B 2018;178:92-100. [PMID: 29128706 DOI: 10.1016/j.jphotobiol.2017.11.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
8 Xu B, Huang S, Wang C, Zhang H, Fang S, Zhang Y. Anti‑inflammatory effects of dihydromyricetin in a mouse model of asthma. Mol Med Rep 2017;15:3674-80. [PMID: 28393183 DOI: 10.3892/mmr.2017.6428] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
9 Chang Y, Yuan L, Liu J, Muhammad I, Cao C, Shi C, Zhang Y, Li R, Li C, Liu F. Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway. Vet Res 2020;51:72. [PMID: 32448367 DOI: 10.1186/s13567-020-00796-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Liu TT, Zeng Y, Tang K, Chen X, Zhang W, Xu XL. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice. Atherosclerosis 2017;262:39-50. [PMID: 28500865 DOI: 10.1016/j.atherosclerosis.2017.05.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
11 Deng X, Hou Y, Zhou H, Li Y, Xue Z, Xue X, Huang G, Huang K, He X, Xu W. Hypolipidemic, anti-inflammatory, and anti-atherosclerotic effects of tea before and after microbial fermentation. Food Sci Nutr 2021;9:1160-70. [PMID: 33598200 DOI: 10.1002/fsn3.2096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zhu XH, Lang HD, Wang XL, Hui SC, Zhou M, Kang C, Yi L, Mi MT, Zhang Y. Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models. Food Funct 2019;10:2040-9. [PMID: 30907395 DOI: 10.1039/c8fo01756e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
13 Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J, Zhou Q, Meng G, Yang S. Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin. Front Pharmacol. 2018;9:1204. [PMID: 30410442 DOI: 10.3389/fphar.2018.01204] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
14 Sklenarova R, Svrckova M, Hodek P, Ulrichova J, Frankova J. Effect of the natural flavonoids myricetin and dihydromyricetin on the wound healing process in vitro. J Appl Biomed 2021;19:149-58. [PMID: 34907758 DOI: 10.32725/jab.2021.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li H, Li Q, Liu Z, Yang K, Chen Z, Cheng Q, Wu L. The Versatile Effects of Dihydromyricetin in Health. Evid Based Complement Alternat Med 2017;2017:1053617. [PMID: 28947908 DOI: 10.1155/2017/1053617] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
16 Xiao XN, Wang F, Yuan YT, Liu J, Liu YZ, Yi X. Antibacterial Activity and Mode of Action of Dihydromyricetin from Ampelopsis grossedentata Leaves against Food-Borne Bacteria. Molecules 2019;24:E2831. [PMID: 31382605 DOI: 10.3390/molecules24152831] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
17 Feng L, Que D, Li Z, Zhong X, Yan J, Wei J, Zhang X, Yang P, Ou C, Chen M. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clin Sci (Lond) 2021;135:2483-502. [PMID: 34643227 DOI: 10.1042/CS20210259] [Reference Citation Analysis]
18 Li MY, Mi C, Wang KS, Wang Z, Zuo HX, Piao LX, Xu GH, Li X, Ma J, Jin X. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling. Chem Biol Interact 2017;274:58-67. [PMID: 28684144 DOI: 10.1016/j.cbi.2017.06.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
19 Mu HQ, He YH, Wang SB, Yang S, Wang YJ, Nan CJ, Bao YF, Xie QP, Chen YH. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Clin Transl Oncol 2020;22:111-21. [PMID: 31667686 DOI: 10.1007/s12094-019-02217-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
20 Govindarajulu M, Ramesh S, Neel L, Fabbrini M, Buabeid M, Fujihashi A, Dwyer D, Lynd T, Shah K, Mohanakumar KP, Smith F, Moore T, Dhanasekaran M. Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease. Neurochem Int 2021;144:104958. [PMID: 33444675 DOI: 10.1016/j.neuint.2021.104958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Xie W, Du Y, Yuan S, Pang J. Dihydromyricetin incorporated active films based on konjac glucomannan and gellan gum. Int J Biol Macromol 2021;180:385-91. [PMID: 33652043 DOI: 10.1016/j.ijbiomac.2021.02.185] [Reference Citation Analysis]
22 Chang TM, Hsiao TC, Yang TY, Huang HC. IgE-Induced Mast Cell Activation Is Suppressed by Dihydromyricetin through the Inhibition of NF-κB Signaling Pathway. Molecules 2021;26:3877. [PMID: 34201934 DOI: 10.3390/molecules26133877] [Reference Citation Analysis]
23 Ren Z, Yan P, Zhu L, Yang H, Zhao Y, Kirby BP, Waddington JL, Zhen X. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation. Psychopharmacology (Berl) 2018;235:233-44. [PMID: 29058041 DOI: 10.1007/s00213-017-4761-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
24 Zhao L, Cai C, Wang J, Zhao L, Li W, Liu C, Guan H, Zhu Y, Xiao J. Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity. Front Pharmacol 2017;8:928. [PMID: 29311931 DOI: 10.3389/fphar.2017.00928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
25 Jia R, Ma J, Meng W, Wang N. Dihydromyricetin inhibits caerulin-induced TRAF3-p38 signaling activation and acute pancreatitis response. Biochem Biophys Res Commun 2018;503:1696-702. [PMID: 30055802 DOI: 10.1016/j.bbrc.2018.07.101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
26 Chen YL, Zhang YL, Dai YC, Tang ZP. Systems pharmacology approach reveals the antiinflammatory effects of Ampelopsis grossedentata on dextran sodium sulfate-induced colitis. World J Gastroenterol 2018; 24(13): 1398-1409 [PMID: 29632421 DOI: 10.3748/wjg.v24.i13.1398] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
27 Liu X, Xing Y, Li M, Zhang Z, Wang J, Ri M, Jin C, Xu G, Piao L, Jin H, Zuo H, Ma J, Jin X. Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-κB and Ras/Raf/MEK pathways. J Ethnopharmacol 2021;273:113989. [PMID: 33677006 DOI: 10.1016/j.jep.2021.113989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sun Y, Liu S, Yang S, Chen C, Yang Y, Lin M, Liu C, Wang W, Zhou X, Ai Q, Wang W, Chen N. Mechanism of Dihydromyricetin on Inflammatory Diseases. Front Pharmacol 2022;12:794563. [DOI: 10.3389/fphar.2021.794563] [Reference Citation Analysis]